Skip Navigation

Johns Hopkins Bloomberg School of Public Health

Johns Hopkins Bloomberg School of Public Health: The INFO Project

Your knowledge-sharing resource on family planning and reproductive health

Universal Navigation:
INFO Home  |  Order  |  e-lists  |  Search Web Site  |  Contact Us  |  Press  |  Site Map  |  Espaņol/Francais

Shopping Basket

Info Reports Logo

Injectable Contraceptives: Tools for Providers



From INFO's Toolbox
December 2006
Issue No. 8
The INFO Project • Johns Hopkins Bloomberg School of Public Health • Center for Communication Programs • 111 Market Place, Suite 310 • Baltimore, Maryland 21202, USA • 410-659-6300 • 410-659-6266 (fax) • www.infoforhealth.orginfoproject@jhuccp.org
PDF version of the INFO Reports, December 2006, Number 8, Injectable Contraceptives: Tools for Providers

Checklist for Screening Clients Who
Want to Initiate DMPA (or NET-EN)

A tool from Family Health International to help providers use the WHO Medical Eligibility Criteria

Research findings have established that depot medroxyprogesterone acetate (DMPA) and norethisterone enantate (NET-EN) are safe and effective for use by most women, including those who are at risk of sexually transmitted infections (STIs) and those living with or at risk of HIV infection. For some women, DMPA and NET-EN are usually not recommended or are contraindicated because of the presence of certain medical conditions such as liver tumors and breast cancer.

This checklist (see next page) is designed for use by both clinical and nonclinical health care providers, including community health workers, to help screen clients who were counseled about contraceptive options and made an informed decision to use DMPA. It consists of 13 questions designed to identify medical conditions that would prevent safe DMPA use or require further screening, as well as to provide further guidance and directions based on clients' responses. Clients who are ruled out because of their response to some of the medical eligibility or pregnancy questions may still be good candidates for DMPA after the suspected condition is excluded through appropriate evaluation. The checklist is based on recommendations by the World Health Organization in the Medical Eligibility Criteria for Contraceptive Use (212).

This checklist is part of a series of provider checklists developed by Family Health International (FHI), with support from the U.S. Agency for International Development (USAID). The checklist is included in this issue of INFO Reports as a collaborative distribution service of the INFO Project. For more information, please visit www.fhi.org.

Assessing Medical Eligibility for DMPA

  1. Have you ever had a stroke, blood clot in your legs or lungs, or heart attack?
    This question is intended to identify women with already known serious vascular disease, not to determine whether women might have an undiagnosed condition. Women with these conditions may be at somewhat increased risk of blood clots if they use DMPA. Women who have had any of these conditions will commonly have been told that they have had this condition and will answer "yes," if appropriate.
  2. Have you ever been told you have breast cancer?
    This question is intended to identify women who know they have had or currently have breast cancer. These women are not good candidates for DMPA because breast cancer is a hormone-sensitive tumor, and DMPA use may adversely affect the course of the disease.
  3. Do you have a serious liver disease or jaundice (yellow skin or eyes)?
    This question is intended to identify women who know that they currently have a serious liver disease and to distinguish between current severe liver disease (such as severe cirrhosis or liver tumors) and past liver problems (such as treated hepatitis). Women with serious liver disease should not generally use DMPA because it is processed by the liver and hence its use may adversely affect women whose liver function is already weakened by the disease.
  4. Have you ever been told you have diabetes (high sugar in your blood)?
    This question is intended to identify women who know that they have diabetes, not to assess whether they may have an undiagnosed condition. Women who have had diabetes for 20 years or longer or those with vascular complications should generally not use DMPA because of the increased risk of blood clots. Evaluate or refer for evaluation as appropriate and, if these complications are absent, the woman may still be a good candidate for DMPA.
  5. Have you ever been told you have high blood pressure?
    This question is intended to identify women who may have high blood pressure. These women should be evaluated or referred for evaluation as appropriate. Based on evaluation, women with blood pressure levels of 160/100 mm Hg or more should not initiate DMPA.
 
  1. Do you have bleeding between menstrual periods, which is unusual for you, or bleeding after intercourse (sex)?
    This question is intended to identify women who may have an underlying pathological condition. While DMPA use does not make these conditions worse, it may change the bleeding pattern and mask a serious underlying condition. Unusual bleeding changes may indicate pregnancy or tumor that should be evaluated soon or treated by a higher-level health care provider. DMPA use should be delayed until the condition can be evaluated. In contrast, women for whom it is not unusual to have heavy or prolonged bleeding, or irregular bleeding patterns, may safely initiate DMPA use.
  2. Are you currently breastfeeding a baby less than six weeks old?
    This question is included because of the theoretical concern that hormones in breastmilk can have an adverse effect on a newborn during the first six weeks after birth. A breastfeeding woman can initiate DMPA six weeks after her baby is born.
    -----------------------------------------------
    Note: Clients with multiple risk factors for cardiovascular disease (e.g., a combination of older age, smoking, and diabetes even without complications) generally are not good candidates for DMPA.

Determining Current Pregnancy

Questions 8–13 of the checklist are intended to help a provider determine, with reasonable certainty, whether a client is not pregnant. If a client answers "yes" to any of these questions and there are no signs or symptoms of pregnancy, it is highly likely that she is not pregnant. The client can start DMPA now.

If the client is within 7 days of the start of her menstrual bleeding, she can start the method immediately. No back-up method is needed.

If it has been more than 7 days since her first day of bleeding, she can start DMPA immediately but must use a back-up method (i.e., using a condom or abstaining from sex) for 7 days to ensure adequate time for the DMPA to become effective.

If you cannot determine with reasonable certainty that your client is not pregnant (using the checklist) and if you do not have access to a pregnancy test, then she needs to wait until her next menstrual period begins before starting DMPA. She should be given condoms to use in the meantime.


Go to Previous Page  Go to Next Page
Back to top

Disclaimer: The information provided on this web site is not official U.S. Government information and does not represent the views or positions of the U.S. Agency for International Development, the U.S. Government or The Johns Hopkins University.